The effect of dental pulp mesenchymal stem cells in treatment of corona disease
Phase 2
Recruiting
- Conditions
- U07.1COVID19, virus identifiedCorona virus disease.
- Registration Number
- IRCT20140911019125N8
- Lead Sponsor
- Kerman University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Patients aged between 18-95 years
Patients Approved for Covirus 19 by Laboratory Methods
Patients with mild to moderate respiratory distress
Hospitalization in the IC
Exclusion Criteria
Patients undergoing other clinical trials
Patients with underlying diseases including diabetes, heart disease, respiratory disease, cancer patients and patients undergoing chemotherapy.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pulmonary Condition. Timepoint: At the beginning of the study and 1 day and 2 days, 4 days, 7 days and 14 days after the start of the study. Method of measurement: CT scan.;Expression of nucleic acid of virus. Timepoint: At the beginning of the study and 1 day and 2 days, 4 days, 7 days and 14 days after the start of the study. Method of measurement: real time PCR.;Lymphocytes count. Timepoint: At the beginning of the study and 1 day and 2 days, 4 days, 7 days and 14 days after the start of the study. Method of measurement: Flowcytometry.;Patients clinical signs. Timepoint: At the beginning of the study and 1 day and 2 days, 4 days, 7 days and 14 days after the start of the study. Method of measurement: Observation.
- Secondary Outcome Measures
Name Time Method